Comparison
These are not really the same purchase. Abridge is bought by a health system over months; SyntheNote is bought by a clinician in an afternoon. If you have an IT department and an Epic integration budget, Abridge is the serious option. If you are the IT department, this comparison is the point.
“Trusted by 300+ health systems”— Abridge's own positioning
Abridge is the enterprise benchmark in this category and deserves the description: deployments at Kaiser Permanente and Johns Hopkins, Best in KLAS in 2025 and 2026, and deep EHR integration work of a kind that takes a health system’s IT department to land. It is sold to the organisation, not to the clinician, and it is priced that way.
| SyntheNote | Abridge | |
|---|---|---|
| Who buys it | The clinician, self-serve | The health system, through a sales process |
| Price | Free, then $13.99–$199 a month, published | Not published — enterprise contract |
| Time to first note | Same day; download the app and record | An enterprise deployment |
| Free path | Free plan, no card | None public |
| EHR integration | Export and copy; no direct write-back yet | Deep EHR integration, including write-back |
| Grounding check | Every sentence traced to the transcript, unsupported ones flagged | Not published in these terms |
| Track record | New | 300+ health systems; Best in KLAS 2025 and 2026 |
On enterprise ground Abridge wins and it is not close: EHR write-back, health-system deployments, and third-party validation SyntheNote has none of yet. If your notes must land inside Epic automatically, SyntheNote cannot do that today and Abridge can. We are the better answer for the clinician who is not buying through an institution at all.
The free plan covers 10 recordings a month and needs no card. That is enough to find out whether the note is one you would sign.